Institutional investors purchased a net $32.9 million shares of KERX during the quarter ended December 2012 and now own 67.03% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Other institutional | 50.94% |
| Individual stakeholders | 18.02% |
| Mutual fund holders | 16.09% |